News
Spinout
Resolution Therapeutics doses first patient in clinical trial
Biopharmaceutical spinout Resolution Therapeutics has announced the first patient has been dosed and safety cleared in the Phase I/II EMERALD study of its novel therapy for end-stage liver disease.







